Micron Technology
MU
NVIDIA
NVDA
Adobe
ADBE
4
Tesla
TSLA
5
Netflix
NFLX
US Stock MarketDetailed Quotes
IPHA Innate Pharma
- 2.000
- +0.005+0.25%
Close Mar 14 16:00 ET
- 1.920
- -0.080-4.00%
Post 17:31 ET
167.62MMarket Cap-4.39P/E (TTM)
2.000High1.920Low17.92KVolume1.990Open1.995Pre Close35.41KTurnover0.03%Turnover RatioLossP/E (Static)83.81MShares3.51152wk High5.36P/B116.23MFloat Cap1.29052wk Low--Dividend TTM58.11MShs Float11.950Historical High--Div YieldTTM4.01%Amplitude1.290Historical Low1.975Avg Price1Lot Size
About Innate Pharma Company
Innate Pharma SA is a global, clinical-stage biotechnology company, which engages in developing immunotherapies for cancer patients. Its product pipeline includes Lacutamab, Monalizumab, Avdoralimab, and IPH62. The company was founded by Hervé Eloi Dominique Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié, and Fran?ois Romagné on September 23, 1999 and is headquartered in Marseille, France.
Company Profile
SymbolIPHA
Company NameInnate Pharma
Listing DateOct 17, 2019
Issue Price5.50
Founded1999
CEODr. Mondher Mahjoubi, M.D.
MarketNASDAQ
Employees179
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address117, Avenue de Luminy
CityMarseille
ProvinceProvence-Alpes-Cote-dAzur
CountryFrance
Zip Code13009
Phone33-4-30-30-30-30
Websitehttp://www.innate-pharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Mondher Mahjoubi, M.D.
- Chairman of the Executive Board and Chief Executive Officer
- --
- Frederic Lombard
- Chief Financial Officer
- --
- Sonia Quaratino
- Chief Medical Officer and Executive Vice President
- --
- Nicola Beltraminelli
- Vice President and Chief Development Officer
- --
- Eric Vivier, PhD
- Senior Vice President and Chief Scientific Officer
- --
- Odile Laurent
- Vice President, Human Resources
- --
- Yannis Morel, PhD
- Member of the Executive Board and Executive Vice President, Product Portfolio Strategy and Business Development
- --
- Odile Belzunce
- Vice President, Compliance, IT and Portfolio Management
- --
- Henry Wheeler
- Vice President, Investor Relations and Communications
- --
- Claire de Saint Blanquat
- Vice President, Legal and Corporate Affairs
- --
- Herve Brailly, PhD
- Chairman of the Supervisory Board
- --
- Irina Staatz-Granzer, PhD
- Vice Chairman of the Supervisory Board
- --
- Professor Jean-Yves Blay, PhD
- Member of the Supervisory Board
- --
- Sally Bennett
- Member of the Supervisory Board
- --
- Olivier Martinez
- Member of the Supervisory Board
- --
- Pascale Boissel
- Member of the Supervisory Board
- --
- Dr. Veronique Chabernaud, M.D.
- Member of the Supervisory Board
- --
- Gilles Brisson
- Member of the Supervisory Board
- --
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call